2022 recipient
Matthew C. Kiernan, AM, MBBS, PhD, DSc
Professor Matthew Kiernan is a true research leader in ALS. His stewardship of the Pan-Asian Consortium for the Treatment of ALS has played a pivotal role in improving care and driving ALS research worldwide. His leadership in establishing new consensus guidelines for ALS has simplified diagnosis and will improve clinical trial enrollment. He has developed important techniques that enable study of disruption of brain networking in ALS, establishing novel disease biomarkers and mechanisms of disease progression that can be incorporated into future clinical trials.
